S. 1414 · Reported by committee · Jul 27, 2026 · 2 cosponsors, both parties
Reported by committee · Jul 27, 2026 · 2 cosponsors, both parties. Expedited Access to Biosimilars Act This bill modifies statutory requirements for demonstrating that a proposed biological product (e.g., a drug or vaccine) is…